Received Feb 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z012063 | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No adverse effects reported./No additional AE; Nurse called to report a 12 month year old child was administered VARIVAX and PROQUAD together; Nurse called to report a 12 month year old child was administered VARIVAX and PROQUAD together; This spontaneous report was received from a nurse and refers to a 12-month-old and 20 days patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 30-Jan-2026, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (strength, dose, frequency were not reported) (lot #Z012063, expiration date: 18-Jan-2027) and Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (strength, dose, frequency, lot # and expiration date were not reported) together (Inappropriate schedule of vaccine administered) (Vaccine overdose) and diluted with sterile diluent (strength, dose, frequency, expiration date, and lot # were not reported). The vaccines were administered for prophylaxis. No adverse effects reported. Lot # is being requested and will be submitted if received.
STERILE DILUENT